GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Total Liabilities

U2Bio Co (XKRX:221800) Total Liabilities : ₩11,208 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Total Liabilities?

U2Bio Co's Total Liabilities for the quarter that ended in Dec. 2023 was ₩11,208 Mil.

U2Bio Co's quarterly Total Liabilities declined from Dec. 2022 (₩17,184.21 Mil) to Jun. 2023 (₩10,460.47 Mil) but then increased from Jun. 2023 (₩10,460.47 Mil) to Dec. 2023 (₩11,207.98 Mil).

U2Bio Co's annual Total Liabilities declined from Dec. 2021 (₩19,810.62 Mil) to Dec. 2022 (₩17,184.21 Mil) and declined from Dec. 2022 (₩17,184.21 Mil) to Dec. 2023 (₩11,207.98 Mil).


U2Bio Co Total Liabilities Historical Data

The historical data trend for U2Bio Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Total Liabilities Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 14,641.11 17,055.63 19,810.62 17,184.21 11,207.98

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Total Liabilities - 17,184.21 10,460.47 11,207.98

U2Bio Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

U2Bio Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8003.148+(191.958+0.00099999999974898
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+3012.874)
=11,208

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=49199.391-37991.41
=11,208

U2Bio Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8003.148+(191.958+0.00099999999974898
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+3012.874)
=11,208

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=49199.391-37991.41
=11,208

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U2Bio Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co (XKRX:221800) Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines